Effect of High Dose Intravenous Vitamin C in Severe Pneumonia
ConditionPneumonia
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorClinical Research Centre, Malaysia
About this trial
This trial is a multicenter, randomized, double-blind, two-arm, parallel-group, placebo-controlled trial to investigate the effect of high dose intravenous (IV) Vitamin C as an adjunct to the standard of care for patients with severe pneumonia versus placebo in ICU.
Eligibility criteria
Qualifiers
Patients who are aged 18 and above
Patients who are diagnosed with severe pneumonia
Patients who are mechanically ventilated
Disqualifiers
Known allergy to Vitamin C
Pregnancy
Known history of ongoing concomitant infection
Participation in another clinical trial and/or receipt of investigational drugs within 4 weeks prior to enrollment
Trial design
Treatments tested in this trial
- Active Ingredient
- Placebo
Treatment groups
484 Participants
are divided into 2 treatment groupsSponsors and collaborators
Clinical Research Centre, Malaysia
Lead sponsor
Ain Medicare Sdn Bhd
Collaborator
Source ClinicalTrials.gov